| Literature DB >> 18272717 |
Marco Ciotti1, Fabbio Marcuccilli, Tania Guenci, Maria Grazia Prignano, Carlo Federico Perno.
Abstract
The new Abbott RealTime hepatitis B virus (HBV) assay was compared to the Cobas AmpliPrep/Cobas TaqMan assay with 128 serum samples from patients with chronic hepatitis B. There was an excellent correlation (r = 0.961) between the two assays, with the Abbott RealTime test showing at least equivalent sensitivity and a slightly wider dynamic range than the Cobas TaqMan assay. By coupling high sensitivity with a large dynamic range, the Abbott RealTime HBV assay is useful in monitoring the response to antiviral therapy.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18272717 PMCID: PMC2292927 DOI: 10.1128/JCM.02046-07
Source DB: PubMed Journal: J Clin Microbiol ISSN: 0095-1137 Impact factor: 5.948